Global Injectable Drug Delivery Devices Market 2024-2028
Injectable Drug Delivery Devices Market 2024-2028
The injectable drug delivery devices market is forecasted to grow by USD 29562.9 mn during 2023-2028, accelerating at a CAGR of 10.8% during the forecast period. The report on the injectable drug delivery devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic diseases, growing biologics industry, and digitalization in healthcare system.
Technavio's injectable drug delivery devices market is segmented as below:
By Product
- Advanced injectable drug delivery devices
- Conventional injectable drug delivery devices
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the high growth potential in emerging countries as one of the prime reasons driving the injectable drug delivery devices market growth during the next few years. Also, growing adoption of self-injectable drug delivery devices and increasing investments in pharmaceutical research and development will lead to sizable demand in the market.
The report on the injectable drug delivery devices market covers the following areas:
- Injectable Drug Delivery Devices Market sizing
- Injectable Drug Delivery Devices Market forecast
- Injectable Drug Delivery Devices Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading injectable drug delivery devices market vendors that include Antares Pharma Inc., AstraZeneca Plc, B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Bespak Europe Ltd., Credence MedSystems Inc., E3D Elcam Drug Delivery Devices, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gerresheimer AG, Insulet Corp., Owen Mumford Ltd., Sanofi SA, SCHOTT AG, SHL Medical AG, Terumo Corp., Teva Pharmaceutical Industries Ltd., Viatris Inc., and West Pharmaceutical Services Inc.. Also, the injectable drug delivery devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.